For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as foreign, destroy it, and "remember" it, so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters.
Travelers are at increased risk for several infections, including familiar infections such as measles that are widely distributed but more common in developing countries. Travelers Vaccines can markedly decrease the risk for many of these infections and are an important part of pretravel preparation.
In this report, the travelers vaccines mainly covers vaccine for hepatitis A, hepatitis B, rabies, typhoid fever, yellow fever, Japanese encephalitis, meningococcal meningitis, cholera, etc.
LPI (LP Information)' newest research report, the "Travelers Vaccines Industry Forecast" looks at past sales and reviews total world Travelers Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Travelers Vaccines sales for 2023 through 2029. With Travelers Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Travelers Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Travelers Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Travelers Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Travelers Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Travelers Vaccines and breaks down the forecast by type, by end users, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Travelers Vaccines.
The global Travelers Vaccines market size is projected to grow from US$ 3290.1 million in 2022 to US$ 6064.5 million in 2029; it is expected to grow at a CAGR of 6064.5 from 2023 to 2029.
Merck, GlaxoSmithKline and Sanofi Pasteur are the main manufacturers in the vaccine market, with a market share of more than 60% and a high degree of market concentration. North America and Europe are the main production regions, with market share of more than 40% and 30%.
This report presents a comprehensive overview, market shares, and growth opportunities of Travelers Vaccines market by product type, end users, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Meningococcal Vaccine
- Japanese Encephalitis Vaccine
- Yellow Fever Vaccine
- Hepatitis Vaccine
- Cholera Vaccine
- Other
Segmentation by end users
- Tourists
- Students
- Workers
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- GlaxoSmithKline
- Sanofi Pasteur
- Merck
- Pfizer
- CNBG
- Sanofi Pasteur MSD
- Serum Institute of India
- Biokangtai
Key Questions Addressed in this Report
What is the 10-year outlook for the global Travelers Vaccines market?
What factors are driving Travelers Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Travelers Vaccines market opportunities vary by end market size?
How does Travelers Vaccines break out type, end users?
What are the influences of COVID-19 and Russia-Ukraine war?